60 related articles for article (PubMed ID: 98893)
21. Ergot drugs and central monoaminergic mechanisms: a histochemical, biochemical and behavioral analysis.
Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
Fed Proc; 1978 Jun; 37(8):2181-91. PubMed ID: 350633
[TBL] [Abstract][Full Text] [Related]
22. Pharmacological and biochemical evidence for the dopamine agonistic effect of bromocriptine.
Fuxe K; Fredholm BB; Ogren SO; Agnati LF; Hökfelt T; Gustafsson JA
Acta Endocrinol Suppl (Copenh); 1978; 216():27-56. PubMed ID: 347864
[No Abstract] [Full Text] [Related]
23. Topographical distribution and characteristics of dopamine and beta-adrenergic sensitive adenylate cyclases in the rat frontal cerebral cortex, striatum, and substantia nigra.
Bockaert J; Premont J; Glowinski J; Tassin JP; Thierry AM
Adv Biochem Psychopharmacol; 1977; 16():29-37. PubMed ID: 196489
[No Abstract] [Full Text] [Related]
24. Repeated amphetamine pretreatment alters the responsiveness of striatal dopamine-stimulated adenylate cyclase to amphetamine-induced desensitization.
Barnett JV; Segal DS; Kuczenski R
J Pharmacol Exp Ther; 1987 Jul; 242(1):40-7. PubMed ID: 2956412
[TBL] [Abstract][Full Text] [Related]
25. Desensitization of adenosine and dopamine receptors in rat brain after treatment with adenosine analogs.
Porter NM; Radulovacki M; Green RD
J Pharmacol Exp Ther; 1988 Jan; 244(1):218-25. PubMed ID: 3335999
[TBL] [Abstract][Full Text] [Related]
26. Receptors acting through adenylate cyclase in the CNS.
Wollemann M
Acta Physiol Acad Sci Hung; 1980; 55(4):299-304. PubMed ID: 6258390
[TBL] [Abstract][Full Text] [Related]
27. Dopamine-sensitive adenylate cyclase and receptor binding activities after acute and chronic neuroleptic drug treatment.
Clement-Cormier Y
Adv Biochem Psychopharmacol; 1980; 24():103-11. PubMed ID: 6105768
[No Abstract] [Full Text] [Related]
28. Dopamine-sensitive adenylate cyclase and dopamine/neuroleptic receptor binding: effect of neuroleptic drugs.
Marshall AM; Mishra RK
Adv Biochem Psychopharmacol; 1980; 24():153-7. PubMed ID: 6105772
[No Abstract] [Full Text] [Related]
29. Proceedings:Pre- and postsynaptic actions of neuroleptic drugs.
Iversen LL; Miller RJ; Rogawski M
Br J Pharmacol; 1975 Oct; 55(2):297P-298P. PubMed ID: 1201424
[No Abstract] [Full Text] [Related]
30. [Recent advance in neuropharmacology (author's transl)].
Kayama Y
Masui; 1978 Mar; 27(3):219-28. PubMed ID: 25972
[No Abstract] [Full Text] [Related]
31. Evidence for dopamine receptors mediating sedation in the mouse brain.
Di Chiara G; Porceddu ML; Vargiu L; Argiolas A; Gessa GL
Nature; 1976 Dec; 264(5586):564-7. PubMed ID: 1004597
[No Abstract] [Full Text] [Related]
32. Dopamine and schizophrenia.
Westerink BH; Korf J
Lancet; 1976 Dec; 2(7997):1249-50. PubMed ID: 63073
[No Abstract] [Full Text] [Related]
33. Tranquilizers as energizers.
BARSA JA
Am J Psychiatry; 1958 Dec; 115(6):543. PubMed ID: 13595130
[No Abstract] [Full Text] [Related]
34. [Blockade of the dopamine receptor: a possible mechanism of action of antipsychotic drugs (author's transl)].
Karobath ME
Pharmakopsychiatr Neuropsychopharmakol; 1975 Jul; 8(4):151-61. PubMed ID: 1233518
[TBL] [Abstract][Full Text] [Related]
35. Repartition and drug sensitivity of dopamine and L-isoproterenol-sensitive adenylate cyclases in rat brain homogenates.
Prémont J; Tassin JP; Thierry AM; Bockaert J
Adv Biochem Psychopharmacol; 1976; 15():347-56. PubMed ID: 192054
[TBL] [Abstract][Full Text] [Related]
36. Multiple forms of the D1 dopamine receptor: its linkage to adenylate cyclase and psychopharmacological effects.
Mailman RB; Schulz DW; Kilts CD; Lewis MH; Rollema H; Wyrick S
Psychopharmacol Bull; 1986; 22(3):593-8. PubMed ID: 2879302
[No Abstract] [Full Text] [Related]
37. Studies on the pharmacological properties of dopamine receptors in various areas of the central nervous system.
Spano PF; Govoni S; Trabucchi M
Adv Biochem Psychopharmacol; 1978; 19():155-65. PubMed ID: 358777
[No Abstract] [Full Text] [Related]
38. D1 dopamine receptor--the search for a function: a critical evaluation of the D1/D2 dopamine receptor classification and its functional implications.
Clark D; White FJ
Synapse; 1987; 1(4):347-88. PubMed ID: 2971273
[TBL] [Abstract][Full Text] [Related]
39. Effects of drugs and lesions on dopamine-stimulated adenylate cyclase: evidence for different classes of dopamine receptors.
Katzman R; Makman MH; Ahn HS; Mishra RK; Gardner E
Trans Am Neurol Assoc; 1977; 102():76-9. PubMed ID: 98893
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
